The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

The 19-year-old student opened up about her family's experience of the disaster in an essay written for Yale University's ...

Agency leaders said there was evidence to justify approval only for older people and those with medical conditions. Many ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Millions of "long COVID" patients coping with debilitating "brain fog" and chronic fatigue, who are looking for answers to ...

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

Long COVID—clinically known as post-acute sequelae of SARS-CoV-2 infection (PASC)—is a life-altering condition that affects more than 400 million people worldwide. Symptoms can persist for months or ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...